Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 32

1.

Identification of human D lactate dehydrogenase deficiency.

Monroe GR, van Eerde AM, Tessadori F, Duran KJ, Savelberg SMC, van Alfen JC, Terhal PA, van der Crabben SN, Lichtenbelt KD, Fuchs SA, Gerrits J, van Roosmalen MJ, van Gassen KL, van Aalderen M, Koot BG, Oostendorp M, Duran M, Visser G, de Koning TJ, Calì F, Bosco P, Geleijns K, de Sain-van der Velden MGM, Knoers NV, Bakkers J, Verhoeven-Duif NM, van Haaften G, Jans JJ.

Nat Commun. 2019 Apr 1;10(1):1477. doi: 10.1038/s41467-019-09458-6.

2.

Why the TimeToStop trial failed to recruit: a survey on antiepileptic drug withdrawal after paediatric epilepsy surgery.

Lamberink HJ, Geleijns K, Otte WM, Arzimanoglou A, Helen Cross J, Korff CM, Ramantani G, Braun KPJ.

Epileptic Disord. 2018 Oct 1;20(5):374-385. doi: 10.1684/epd.2018.1003.

PMID:
30378554
3.

Specific EEG markers in POLG1 Alpers' syndrome.

van Westrhenen A, Cats EA, van den Munckhof B, van der Salm SMA, Teunissen NW, Ferrier CH, Leijten FSS, Geleijns KPW.

Clin Neurophysiol. 2018 Oct;129(10):2127-2131. doi: 10.1016/j.clinph.2018.07.016. Epub 2018 Aug 4.

PMID:
30103161
4.

Incidence and outcome of acquired demyelinating syndromes in Dutch children: update of a nationwide and prospective study.

de Mol CL, Wong YYM, van Pelt ED, Ketelslegers IA, Bakker DP, Boon M, Braun KPJ, van Dijk KGJ, Eikelenboom MJ, Engelen M, Geleijns K, Haaxma CA, Niermeijer JMF, Niks EH, Peeters EAJ, Peeters-Scholte CMPCD, Poll-The BT, Portier RP, de Rijk-van Andel JF, Samijn JPA, Schippers HM, Snoeck IN, Stroink H, Vermeulen RJ, Verrips A, Visscher F, Vles JSH, Willemsen MAAP, Catsman-Berrevoets CE, Hintzen RQ, Neuteboom RF.

J Neurol. 2018 Jun;265(6):1310-1319. doi: 10.1007/s00415-018-8835-6. Epub 2018 Mar 22.

5.

Individualized prediction of seizure relapse and outcomes following antiepileptic drug withdrawal after pediatric epilepsy surgery.

Lamberink HJ, Boshuisen K, Otte WM, Geleijns K, Braun KPJ; TimeToStop Study Group.

Epilepsia. 2018 Mar;59(3):e28-e33. doi: 10.1111/epi.14020. Epub 2018 Feb 15.

6.

Individualised prediction model of seizure recurrence and long-term outcomes after withdrawal of antiepileptic drugs in seizure-free patients: a systematic review and individual participant data meta-analysis.

Lamberink HJ, Otte WM, Geerts AT, Pavlovic M, Ramos-Lizana J, Marson AG, Overweg J, Sauma L, Specchio LM, Tennison M, Cardoso TMO, Shinnar S, Schmidt D, Geleijns K, Braun KPJ.

Lancet Neurol. 2017 Jul;16(7):523-531. doi: 10.1016/S1474-4422(17)30114-X. Epub 2017 May 5. Review. Erratum in: Lancet Neurol. 2017 Aug;16(8):584.

PMID:
28483337
7.

Risks and Benefits of Rituximab in the Treatment of Hashimoto Encephalopathy in Children: Two Case Reports and a Mini Review.

Maas A, Braun KP, Geleijns K, Jansen FE, van Royen-Kerkhof A.

Pediatr Neurol. 2017 Jan;66:28-31. doi: 10.1016/j.pediatrneurol.2016.09.002. Epub 2016 Sep 20. Review.

PMID:
27789116
8.

Cognitive consequences of early versus late antiepileptic drug withdrawal after pediatric epilepsy surgery, the TimeToStop (TTS) trial: study protocol for a randomized controlled trial.

Boshuisen K, Lamberink HJ, van Schooneveld MM, Cross JH, Arzimanoglou A, van der Tweel I, Geleijns K, Uiterwaal CS, Braun KP.

Trials. 2015 Oct 26;16:482. doi: 10.1186/s13063-015-0989-2.

9.

Antiepileptic drug withdrawal in medically and surgically treated patients: a meta-analysis of seizure recurrence and systematic review of its predictors.

Lamberink HJ, Otte WM, Geleijns K, Braun KP.

Epileptic Disord. 2015 Sep;17(3):211-28. doi: 10.1684/epd.2015.0764. Review.

10.

Innate Immunity to Campylobacter jejuni in Guillain-Barré Syndrome.

Huizinga R, van den Berg B, van Rijs W, Tio-Gillen AP, Fokkink WJ, Bakker-Jonges LE, Geleijns K, Samsom JN, van Doorn PA, Laman JD, Jacobs BC.

Ann Neurol. 2015 Sep;78(3):343-54. doi: 10.1002/ana.24442. Epub 2015 Jun 30.

PMID:
26017721
11.

Telomere length and telomerase complex mutations in pediatric acute myeloid leukemia.

Aalbers AM, Calado RT, Young NS, Zwaan CM, Wu C, Kajigaya S, Coenen EA, Baruchel A, Geleijns K, de Haas V, Kaspers GJ, Kuijpers TW, Reinhardt D, Trka J, Zimmermann M, Pieters R, van der Velden VH, van den Heuvel-Eibrink MM.

Leukemia. 2013 Aug;27(8):1786-9. doi: 10.1038/leu.2013.57. Epub 2013 Feb 21. No abstract available.

12.

Absence of SBDS mutations in sporadic paediatric acute myeloid leukaemia.

Aalbers AM, Calado RT, Young NS, Zwaan CM, Kajigaya S, Baruchel A, Geleijns K, de Haas V, Kaspers GJ, Reinhardt D, Trka J, Kuijpers TW, Pieters R, van der Velden VH, van den Heuvel-Eibrink MM.

Br J Haematol. 2013 Feb;160(4):559-61. doi: 10.1111/bjh.12134. Epub 2012 Nov 28. No abstract available.

13.

Effect of glucocorticoid receptor gene polymorphisms in Guillain-Barré syndrome.

Dekker MJ, van den Akker EL, Koper JW, Manenschijn L, Geleijns K, Ruts L, van Rijs W, Tio-Gillen AP, van Doorn PA, Lamberts SW, Jacobs BC.

J Peripher Nerv Syst. 2009 Jun;14(2):75-83. doi: 10.1111/j.1529-8027.2009.00216.x.

PMID:
19691529
14.

[Radiation exposure in computed tomography in the Netherlands: risk-benefit analysis].

Stoker J, Kipp JB, Geleijns K, van der Molen AJ, Venema HW.

Ned Tijdschr Geneeskd. 2009 Feb 21;153(8):348-52. Review. Dutch. No abstract available.

PMID:
19294940
15.

Susceptibility to Guillain-Barré syndrome is not associated with CD1A and CD1E gene polymorphisms.

Kuijf ML, Geleijns K, Ennaji N, van Rijs W, van Doorn PA, Jacobs BC.

J Neuroimmunol. 2008 Dec 15;205(1-2):110-2. doi: 10.1016/j.jneuroim.2008.08.013. Epub 2008 Oct 5.

PMID:
18838176
16.

Mannose-binding lectin polymorphisms are not associated with rheumatoid arthritis--confirmation in two large cohorts.

van de Geijn FE, Hazes JM, Geleijns K, Emonts M, Jacobs BC, Dufour-van den Goorbergh BC, Dolhain RJ.

Rheumatology (Oxford). 2008 Aug;47(8):1168-71. doi: 10.1093/rheumatology/ken226. Epub 2008 Jun 18.

PMID:
18562462
17.

Subclass IgG to motor gangliosides related to infection and clinical course in Guillain-Barré syndrome.

Jacobs BC, Koga M, van Rijs W, Geleijns K, van Doorn PA, Willison HJ, Yuki N.

J Neuroimmunol. 2008 Feb;194(1-2):181-90. doi: 10.1016/j.jneuroim.2007.11.017. Epub 2008 Feb 21.

PMID:
18178257
18.

Genetic polymorphisms of macrophage-mediators in Guillain-Barré syndrome.

Geleijns K, Emonts M, Laman JD, van Rijs W, van Doorn PA, Hermans PW, Jacobs BC.

J Neuroimmunol. 2007 Oct;190(1-2):127-30. Epub 2007 Aug 30.

PMID:
17761309
19.

Mannose-binding lectin contributes to the severity of Guillain-Barré syndrome.

Geleijns K, Roos A, Houwing-Duistermaat JJ, van Rijs W, Tio-Gillen AP, Laman JD, van Doorn PA, Jacobs BC.

J Immunol. 2006 Sep 15;177(6):4211-7.

20.

Diagnostic value of anti-GM1 ganglioside serology and validation of the INCAT-ELISA.

Kuijf ML, van Doorn PA, Tio-Gillen AP, Geleijns K, Ang CW, Hooijkaas H, Hop WC, Jacobs BC.

J Neurol Sci. 2005 Dec 15;239(1):37-44. Epub 2005 Sep 8.

PMID:
16154154
21.

Severity of Guillain-Barré syndrome is associated with Fc gamma Receptor III polymorphisms.

van Sorge NM, van der Pol WL, Jansen MD, Geleijns KP, Kalmijn S, Hughes RA, Rees JH, Pritchard J, Vedeler CA, Myhr KM, Shaw C, van Schaik IN, Wokke JH, van Doorn PA, Jacobs BC, van de Winkel JG, van den Berg LH.

J Neuroimmunol. 2005 May;162(1-2):157-64.

PMID:
15833371
22.

Fas polymorphisms are associated with the presence of anti-ganglioside antibodies in Guillain-Barre syndrome.

Geleijns K, Laman JD, van Rijs W, Tio-Gillen AP, Hintzen RQ, van Doorn PA, Jacobs BC.

J Neuroimmunol. 2005 Apr;161(1-2):183-9.

PMID:
15748958
23.

Marker Configuration Model-Based Roentgen Fluoroscopic Analysis.

Garling EH, Kaptein BL, Geleijns K, Nelissen RG, Valstar ER.

J Biomech. 2005 Apr;38(4):893-901.

PMID:
15713311
24.

Atrial fibrillation: multi-detector row CT of pulmonary vein anatomy prior to radiofrequency catheter ablation--initial experience.

Jongbloed MR, Dirksen MS, Bax JJ, Boersma E, Geleijns K, Lamb HJ, van der Wall EE, de Roos A, Schalij MJ.

Radiology. 2005 Mar;234(3):702-9. Epub 2005 Jan 21.

PMID:
15665218
25.

HLA class II alleles are not a general susceptibility factor in Guillain-Barré syndrome.

Geleijns K, Schreuder GM, Jacobs BC, Sintnicolaas K, van Koningsveld R, Meulstee J, Laman JD, van Doorn PA.

Neurology. 2005 Jan 11;64(1):44-9.

PMID:
15642902
26.

Associations with autoimmune disorders and HLA class I and II antigens in inclusion body myositis.

Badrising UA, Schreuder GM, Giphart MJ, Geleijns K, Verschuuren JJ, Wintzen AR, Maat-Schieman ML, van Doorn P, van Engelen BG, Faber CG, Hoogendijk JE, de Jager AE, Koehler PJ, de Visser M, van Duinen SG; Dutch IBM Study Group.

Neurology. 2004 Dec 28;63(12):2396-8.

PMID:
15623710
27.

The occurrence of Guillain-Barre syndrome within families.

Geleijns K, Brouwer BA, Jacobs BC, Houwing-Duistermaat JJ, van Duijn CM, van Doorn PA.

Neurology. 2004 Nov 9;63(9):1747-50.

PMID:
15534275
28.

Functional polymorphisms in LPS receptors CD14 and TLR4 are not associated with disease susceptibility or Campylobacter jejuni infection in Guillain-Barré patients.

Geleijns K, Jacobs BC, Van Rijs W, Tio-Gillen AP, Laman JD, van Doorn PA.

J Neuroimmunol. 2004 May;150(1-2):132-8.

PMID:
15081257
29.

Anti-GM1 IgG antibodies induce leukocyte effector functions via Fcgamma receptors.

van Sorge NM, van den Berg LH, Geleijns K, van Strijp JA, Jacobs BC, van Doorn PA, Wokke JH, van de Winkel JG, Leusen JH, van der Pol WL.

Ann Neurol. 2003 May;53(5):570-9.

PMID:
12730990
30.

Screening for anti-ganglioside antibodies in hypocretin-deficient human narcolepsy.

Overeem S, Geleijns K, Garssen MP, Jacobs BC, van Doorn PA, Lammers GJ.

Neurosci Lett. 2003 Apr 24;341(1):13-6.

PMID:
12676332
31.

Usefulness of dynamic multislice computed tomography of left ventricular function in unstable angina pectoris and comparison with echocardiography.

Dirksen MS, Bax JJ, de Roos A, Jukema JW, van der Geest RJ, Geleijns K, Boersma E, van der Wall EE, Lamb HJ.

Am J Cardiol. 2002 Nov 15;90(10):1157-60. No abstract available.

PMID:
12423725
32.

Radiation hazards involved in CT dacryocystography.

Hermina LR, Geleijns K, Beyerinck D.

AJR Am J Roentgenol. 1999 Dec;173(6):1708-9. No abstract available.

PMID:
10584824

Supplemental Content

Loading ...
Support Center